Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Hemasri Tokala , Jagadeesh K Kalavakunta , Heather Laird-Fick , et al Added: 3 years ago
Abstract Cardiac paragangliomas are the rarest primary cardiac tumours and account for less than one percent of cases. A 24-year-old man presented with complaints of sudden onset of chest pain. The pain started suddenly when he was skiing halfway down the slope and went into a tuck position. Physical examination was significant for elevated jugular venous distension. His electrocardiogram… View more
Author(s): Guy Van Camp , Steven Droogmans , Dirk Kerkhove , et al Added: 3 years ago
Over the last decades, important efforts have been made to miniaturise echocardiographic machines without losing too much accuracy. The first step was to move from big cumbersome machines to echocardiographic laptops. Recently, hand-held ultrasound machines have been developed (see Figure 1). This evolution should facilitate point-of-care cardiac ultrasound – that is, ultrasonography performed… View more
Author(s): John G Coghlan , Denis Pellerin Added: 3 years ago
Goals in Pulmonary Arterial Hypertension Treatment Pulmonary arterial hypertension (PAH) arises from pathological thickening, obstruction and constriction of the pulmonary arterioles.1 This leads to progressive elevation of pulmonary pressures initially on exertion, then at rest.2 Symptoms present late, often only when the pressures can rise little further and the cardiac output (CO) falls due… View more
Author(s): Samir R Kapadia Added: 5 months ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more
Author(s): John G Coghlan , Denis Pellerin Added: 3 years ago
Goals in Pulmonary Arterial Hypertension Treatment Pulmonary arterial hypertension (PAH) arises from pathological thickening, obstruction and constriction of the pulmonary arterioles.1 This leads to progressive elevation of pulmonary pressures initially on exertion, then at rest.2 Symptoms present late, often only when the pressures can rise little further and the cardiac output (CO) falls due… View more
Author(s): HF Pitschner , P Reinesch , H Bahavar , et al Added: 3 years ago
Since 1996 our electrophysiological diagnostic catheters and ablation catheters have been submitted to a certified (DIN EN ISO 13485) reprocessing company (Remed GmbH®, a member of the VANGUARD group). Each step of reprocessing that the catheters have to pass is certified according to the existing international regulations (standards, guidelines, etc.), which is required by law in Germany1,2 and… View more